PEOPLE - Intercytex makes appointment:
This article was originally published in Clinica
Intercytex (Cambridge, UK), a developer of products for the wound care and aesthetics markets based on cell therapy technology, has appointed Jan Benschop as vice-president of commercial development. His initial focus will be to prepare for launch the company's facial rejuvenation product ICX-RHY. Previously, Mr Benschop was general manager (Europe) and a vice-president of Elan Biopharmaceuticals.